Skip to main content
Contact Us
Subscribe
E-Edition
46°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Seagen Inc
(NQ:
SGEN
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Dec 13, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
228.91 (1)
Ask (Size)
228.96 (22)
Prev. Close
228.74
Today's Range
N/A - N/A
52wk Range
211.77 - 228.94
Shares Outstanding
181,934,500
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Steal-of-a-Deal Stocks to Snap Up Right Now
February 26, 2024
Here are three steal-of-a-deal stocks that offer meaningful upside for investors looking for stocks that are on sale now.
Via
InvestorPlace
Outdoing Cancer Requires Pharma To Go Beyond Merely Revolutionizing Existing Treatment
February 22, 2024
Pfizer Inc (NYSE: PFE) is among the many pharmaceutical companies that turned to oncology in response to sinking demand for its COVID-19 products and near patent expiration dates for its several...
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Performance
More News
Read More
Get Rich Quick with These 7 Growth Stocks to Buy Now
February 20, 2024
Via
InvestorPlace
7 Dividend Stocks to Buy at a 52-Week Low
February 12, 2024
Via
InvestorPlace
Pfizer’s 2024 Comeback: A Dividend Gem in the Pharma Market
February 01, 2024
Via
InvestorPlace
Looking Into Seagen's Recent Short Interest
December 13, 2023
Via
Benzinga
Seagen Inc. (NASDAQ: SGEN) is a Leading Gainer in 12/12 Morning Trading
December 12, 2023
Via
Investor Brand Network
What the Options Market Tells Us About Seagen
December 11, 2023
Via
Benzinga
3 Pharma Stocks Could Be the Pills Your Portfolio Needs
January 18, 2024
Via
InvestorPlace
How To Earn $500 A Month From Pfizer Stock
January 02, 2024
Via
Benzinga
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
December 29, 2023
Via
Benzinga
3 Stocks That Are About to Get Absolutely Crushed
December 14, 2023
Via
InvestorPlace
$100 Invested In Seagen 20 Years Ago Would Be Worth This Much Today
December 07, 2023
Via
Benzinga
Pfizer's 2030 Vision Bolstered By Seagen Deal, Analyst Cuts Price Target Amid Conservative 2024 Forecast
December 14, 2023
Via
Benzinga
Pfizer's 2024 Outlook Disappointed Wall Street, But Where Will the Stock Be in 5 Years?
December 14, 2023
Via
The Motley Fool
3 Sleepy Stocks Ready to Wake up in 2024
December 13, 2023
Via
InvestorPlace
Pfizer's Dividend Yield Is 5.7%, Plus Humana And Shake Shack On CNBC's 'Final Trades'
December 13, 2023
Via
Benzinga
Pfizer Stock Tumble Steepens As Seagen Guidance Update Disappoints
December 13, 2023
Via
Investor's Business Daily
Why Is US Pharma Giant Pfizer Stock Trading Lower Today?
December 13, 2023
Via
Benzinga
Pfizer Clears Required Regulatory Hurdles To Complete $43B Seagen Acquisition
December 12, 2023
Via
Benzinga
Bristol Myers Squibb Further Diversifies Oncology Portfolio With Mega $8.4B Deal
December 12, 2023
Via
Benzinga
ADCETRIS® (brentuximab vedotin) Plus Novel Immunotherapy Combination Delivers 100% Progression Free Survival at 12 months in Phase 2 Trial of Patients with Early Stage Classical Hodgkin Lymphoma
December 10, 2023
From
Seagen Inc.
Via
Business Wire
3 Blue-Chip Stocks Set to Make a Comeback in 2024
December 08, 2023
Via
InvestorPlace
TUKYSA® (tucatinib) in Combination with Antibody-Drug Conjugate ado-Trastuzumab Emtansine Improves Progression-Free Survival in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer
December 06, 2023
From
Seagen Inc.
Via
Business Wire
ImmunoGen Stock Nearly Doubled On Thursday: What Happened?
November 30, 2023
Via
Talk Markets
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.